- Joined
- Apr 9, 2009
- Messages
- 3,070
- Points
- 0
LONDON - THE sexually transmitted disease gonorrhoea risks becoming a drug-resistant 'superbug' if doctors do not devise new ways of treating it, a leading sexual health expert said.
Dr Catherine Ison, a specialist on gonorrhoea from Britain's Health Protection Agency said a World Health Organisation (WHO) meeting in Manila next week would be vital to efforts to try to stop the bug repeatedly adapting to and overcoming drugs.
'This is a very clever bacteria. If this problem isn't addressed, there is a real possibility that gonorrhoea will become a very difficult infection to treat,' she said in a telephone interview.
Gonorrhoea is a common bacterial sexually-transmitted infection and if left untreated can lead to pelvic inflammatory disease, ectopic pregnancy and infertility in women. Dr Ison said the highest incidences of gonorrhoea were in south and southeast Asia and sub-Saharan Africa, but as yet the WHO has no breakdown by individual infection type.
Current treatment for gonorrhoea in most countries consists of a single antibiotic dose of either cefixime or ceftriaxone. But Dr Ison, who is due to speak on the issue at a Society for General Microbiology conference in Edinburgh on Tuesday, said strains of the Neisseria gonorrhoeae bacteria were starting to become resistant and could soon become impervious to all current antibiotic treatment options.
Instances of gonorrhoea being resistant to multiple drugs - the definition of a 'superbug' - have started to appear in Japan, where health authorities had decided to up the dose to treat the disease, but stick with the same antibiotic, she said. Other reports of rising gonorrhoea drug resistance had also come from Hong Kong, China, Australia and parts of Asia. -- REUTERS
Dr Catherine Ison, a specialist on gonorrhoea from Britain's Health Protection Agency said a World Health Organisation (WHO) meeting in Manila next week would be vital to efforts to try to stop the bug repeatedly adapting to and overcoming drugs.
'This is a very clever bacteria. If this problem isn't addressed, there is a real possibility that gonorrhoea will become a very difficult infection to treat,' she said in a telephone interview.
Gonorrhoea is a common bacterial sexually-transmitted infection and if left untreated can lead to pelvic inflammatory disease, ectopic pregnancy and infertility in women. Dr Ison said the highest incidences of gonorrhoea were in south and southeast Asia and sub-Saharan Africa, but as yet the WHO has no breakdown by individual infection type.
Current treatment for gonorrhoea in most countries consists of a single antibiotic dose of either cefixime or ceftriaxone. But Dr Ison, who is due to speak on the issue at a Society for General Microbiology conference in Edinburgh on Tuesday, said strains of the Neisseria gonorrhoeae bacteria were starting to become resistant and could soon become impervious to all current antibiotic treatment options.
Instances of gonorrhoea being resistant to multiple drugs - the definition of a 'superbug' - have started to appear in Japan, where health authorities had decided to up the dose to treat the disease, but stick with the same antibiotic, she said. Other reports of rising gonorrhoea drug resistance had also come from Hong Kong, China, Australia and parts of Asia. -- REUTERS
